A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of V120083 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2017
At a glance
- Drugs S 120083 (Primary) ; Naproxen
- Indications Inflammatory pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Purdue Pharma L.P
- 11 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 02 Mar 2017 Status changed from not yet recruiting to recruiting.
- 02 Feb 2017 New trial record